Bristol-Myers Squibb: Earnings Champion Valued Like A Loser (NYSE:BMY)

Bristol-Myers Squibb Company (NYSE: BMY ) share price performance has been weak since "Liberation Day," which mirrors the performance of the entire healthcare industry due to significant political uncertainty. As a result, it might seem that myI am a highly experienced Chief Financial Officer (CFO) with a strong background in the oilfield and real estate industries. With over a decade of experience in finance, I have led numerous complex due diligence efforts and M&A transactions, both domestically and inte ...